Created in 2014 (United States), EGARZO own 126 sister brands and 17477 competing brands. EGARZO is owned by Celgene, listed on the stock exchange of New York EGARZO belongs to the Drug Manufacturers business sector.
Share price brand.technical-problem
Yield (Dividend per share)
(2019-2023) Stoxx Europe 600 : +36.90 % S&P 500 NY : +84.20 %